Expertise in
2
conditions

Pascal Bourquard

Nimes, FR 
Expertise in
2
conditions
Nimes, FR 
OverviewLocationsClinical Research

Overview

Pascal Bourquard practices in Nimes, France. Mr. Bourquard is highly rated in 2 conditions, according to our data. His top areas of expertise are Febrile Neutropenia and Multiple Myeloma.

His clinical research consists of co-authoring 12 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Nimes, 30029, France
Other Locations
Ales, France
La Roche, France
Reims, France
Rennes, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Identification of Genetic Factors Predisposing to Dysglobulinemia
Identification of Genetic Factors Predisposing to Dysglobulinemia
Enrollment Status: Completed
Publish Date: December 15, 2023
Intervention Type: Genetic
Study Phase: Not Applicable
A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial
A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial
Enrollment Status: Completed
Publish Date: July 05, 2023
Intervention Type: Procedure, Drug
Study Drug: Pomalidomide+Cyclophosphamide+Dexamethasone
Study Phase: Phase 2
A Prospective Phase II Study of Bendamustine in Patients Aged Over 60 Years With Classical Hodgkin Lymphoma Treated by Prednisone, Vinblastine and Doxorubicin
A Prospective Phase II Study of Bendamustine in Patients Aged Over 60 Years With Classical Hodgkin Lymphoma Treated by Prednisone, Vinblastine and Doxorubicin
Enrollment Status: Completed
Publish Date: February 21, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

12 Total Publications

Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Therapy-related Myeloid Neoplasms Following PARP Inhibitors: Real-life Experience.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 24, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bourquard's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile